Direct PeptidesProduct page includes use or preparation wordingIn stock
Melanotan II · 10 mg × 10 vials
$619.00$6.19 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
Melanotan II research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 10 mg × 10 vials$6.19 / mg · $619.00Direct Peptides · checked 5 days ago
Listings at 10 mg × 10 vials
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Direct PeptidesProduct page includes use or preparation wording | 10 mg × 10 vials | $619.00 | $6.19 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for Melanotan II. Current means seen in the last 8 days.
| 10 mg × 1 vial | $23.49 | $2.35 / mg | 10 / 11 | 10 |
|---|---|---|---|---|
| 10 mg × 10 vials | $619.00 | $6.19 / mg | 1 / 1 | 1 |
| 10 mg × 1 bottle | $123.98 | — | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- Formerly 503A category 2; nominations withdrawn. Not in any 503A category on FDA's 2026-05-14 listChecked
- Advisory committee (PCAC)
- FDA plans to discuss melanotan II for the 503A list at a PCAC meeting before the end of February 2027Checked
- Rulemaking / enforcement
- No proposed or final rule found (search on 2026-11-03); the only FDA match is a 2016 debarment order in a case about selling melanotan IIChecked
- Identity
- Formula C50H69N15O9 · MW 1024.2 g/mol · CAS 121062-08-6Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2Source record Checked
Identity noteA different molecule from melanotan I (afamelanotide). PT-141 (bremelanotide) differs from melanotan II only at the C-terminal end.
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.